Research projects
Cima Universidad de Navarra
-
RNA and SenescenceActive
Alliance for the monitoring of the centenarian population and nanobiotechnological development associated with healthy aging in Navarra (BIOANCIENT)
Cima Principal Investigator: Marta Montes ResanoFunder: Gobierno de NavarraAward year 2025 -
Active
Inflammatory interactions between respiratory tract cancer and cardiovascular disease: New diagnostic tools and immunomodulatory therapies
Funder: Gobierno de NavarraAward year 2025 -
Radioimmunotherapy strategies for pediatric tumorsActive
Advanced Immunoradiotherapy of Navarra (NAIARA)
Cima Principal Investigator: Sara Labiano AlmiñanaFunder: Gobierno de NavarraAward year 2025 -
Physiological Control and MonitoringActive
Dispositivo MULTISENSORIAL para la detección y posterior tratamiento PERSONALIZADO de heminegligencias y otros daños cerebrales en pacientes con ICTUS mediante Realidad Mixta e Inteligencia Artificial VYSIUM HEALTH
Cima Principal Investigator: Miguel Valencia UstárrozFunder: Gobierno de NavarraAward year 2025 -
Enable TechnologiesActive
3D Bioprinting of tumor organoids in biomimetic matrices (TUMORPRINT3D)
Cima Principal Investigator: Carlos Ortiz de Solórzano AurusaFunder: Gobierno de NavarraAward year 2024 -
Non-Coding RNA and Cancer GenomeActive
Using RNA biology to identify vulnerabilities in ovarian cancer
Cima Principal Investigator: Maite HuarteFunder: Gobierno de Navarra -
Oncogenes and Effector TargetsActive
Characterization of the combined pharmacological inhibition of KRAS and JAK2 in immunocompetent models of pancreatic cancer
Cima Principal Investigator: Julio José Jiménez AlonsoFunder: Asociación Española contra el CáncerAward year 2024 -
RNA and SenescenceActive
RYC2022-036819-I M. MONTES
Cima Principal Investigator: Marta Montes ResanoFunder: Asociación Española contra el CáncerAward year 2023 -
Gene Therapy in Parkinson's DiseaseActive
Calbindin gene therapy for Parkinson's disease
Cima Principal Investigator: José Luis Lanciego PérezFunder: Asociación Española contra el Cáncer -
Medicinal ChemistryActive
Precision tools for immunotherapy of hematological malignancies: development of a synthetic library of nanobodies for therapies based on ADCs and CAR-T cells
Cima Principal Investigator: Antonio Pineda LucenaFunder: Asociación Española contra el Cáncer